IDSA News - May 2014  (Plain Text Version)

Return to Graphical Version

 

In this issue:
Patient Care and Science
•  MERS: What ID Specialists Need to Know
•  HHS Releases Updated Antiretroviral Treatment Guidelines
•  CDC Releases New Guidelines for PrEP
•  USPSTF Issues New Recommendation for Hepatitis B Screening
Clinical Practice Management
•  CMS to Allow Review of Sunshine Disclosures
•  CMS Call for Measures for Federal Reporting Programs
Policy and Advocacy
•  IDSA Submits Comments on Draft National Health Security Strategy
•  IDSA, HIVMA Support Legalization of Syringe Exchange Programs
•  Ryan White Advocacy Days
Global ID
•  amfAR Counts Down to a Cure at Capitol Hill Briefing
•  Uganda’s Dangerous New Criminalization Bill
Education and Resources
•  IDWeek 2014 Mentorship Program
You and Your Colleagues
•  New Members
•  Members on the Move
Top Stories
•  From the President: Nurturing Research Careers
•  IDSA Call for Committee Volunteers
•  SHEA, IDSA Publish Strategies to Prevent SSIs
•  Journal Club

 

MERS: What ID Specialists Need to Know

IDSA’s Rapid Communications Work Group provided IDSA members with up-to-date information on Middle East Respiratory Syndrome (MERS) in an email that was sent to all IDSA members earlier this month. The email provided details on the epidemiology, clinical aspects, and diagnosis of the infection as well as important information on infection control and prevention, and preparedness. See more at: MERS Clinical Update from IDSA.

IDSA offers two email services to help members stay informed of updates from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). Content includes a range of topics, including new drug approvals and warnings. Recent alerts have included:

FDA approves Dalvance to treat skin infections (5/27/14)

CDC announces second imported case of Middle East Respiratory Syndrome (MERS) in the United States (5/13/14)

CDC announces first case of Middle East Respiratory Syndrome Coronavirus infection (MERS) in the United States (5/2/14)

IDSA members can log in to MyIDSA to sign up for these services online.

Is Your Facility Experiencing Antibiotic Shortages?

IDSA members are urged to report drug shortages directly to FDA and to copy IDSA staff at schang@idsociety.org.